ADMA Biologics, Inc.ADMANASDAQ
Loading
Year-over-year net income growth rate
3Y CAGR
+25.7%/yr
vs +9.3%/yr prior
Acceleration
+16.4pp
Accelerating
Percentile
P85
Within normal range
vs 3Y Ago
2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 35.55% |
| Q3 2025 | 6.46% |
| Q2 2025 | 27.19% |
| Q1 2025 | -75.96% |
| Q4 2024 | 211.61% |
| Q3 2024 | 12.00% |
| Q2 2024 | 80.06% |
| Q1 2024 | 200.92% |
| Q4 2023 | -787.90% |
| Q3 2023 | 140.26% |
| Q2 2023 | 6.16% |
| Q1 2023 | 44.50% |
| Q4 2022 | 17.91% |
| Q3 2022 | -8.24% |
| Q2 2022 | 44.96% |
| Q1 2022 | -50.20% |
| Q4 2021 | 6.00% |
| Q3 2021 | 6.31% |
| Q2 2021 | -2.86% |
| Q1 2021 | 5.30% |
| Q4 2020 | -14.72% |
| Q3 2020 | 16.16% |
| Q2 2020 | -4.85% |
| Q1 2020 | -82.23% |
| Q4 2019 | 7.67% |
| Q3 2019 | 13.42% |
| Q2 2019 | -1.10% |
| Q1 2019 | 27.55% |
| Q4 2018 | -19.18% |
| Q3 2018 | -2.63% |
| Q2 2018 | 17.25% |
| Q1 2018 | -37.28% |
| Q4 2017 | 14.60% |
| Q3 2017 | -68.24% |
| Q2 2017 | -38.24% |
| Q1 2017 | -43.38% |
| Q4 2016 | -5.26% |
| Q3 2016 | 27.96% |
| Q2 2016 | -30.35% |
| Q1 2016 | -0.65% |